|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net Income | |||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation and amortization | |||||
| Amortization of operating lease right-of-use assets | |||||
| Amortization of premium/discount on investment securities, net | |||||
| Accretion of lease liability | |||||
| Gain on sale of investment securities | |||||
| Operating lease payments | |||||
| Decrease (increase) in accrued interest receivable | |||||
| (Decrease) increase in accrued interest payable | |||||
| Decrease in unearned fees and unamortized loan origination costs, net | |||||
| (Increase) decrease in income taxes receivable | |||||
| Stock-based compensation expense and tax benefit | |||||
| Provision (benefit) for deferred income taxes | |||||
| Increase (decrease) in accounts payable and accrued liabilities | |||||
| Write down on other real estate owned | |||||
| (Gain) loss on marketable equity securities | |||||
| Loss (gain) on fair value option of junior subordinated debentures | |||||
| Loss on fair value option of junior subordinated debentures | |||||
| Gain on partial redemption of junior subordinated debentures | |||||
| Total loss (gain) on fair value option of junior subordinated debentures | |||||
| Gain on calls of investment securities | |||||
| Gain on proceeds from bank-owned life insurance | |||||
| Increase in cash surrender value of bank-owned life insurance | |||||
| Loss (gain) on sale of assets | |||||
| Net decrease (increase) in other assets | |||||
| Net cash provided by operating activities | |||||
| Cash Flows From Investing Activities: | |||||
| Purchases of FHLB stock, FRB stock, and other securities | |||||
| Maturities and calls of available-for-sale securities | |||||
| Principal payments on available-for-sale securities | |||||
| Purchases of available-for-sale securities | |||||
| Proceeds from sales of available-for-sale securities | |||||
| Net decrease (increase) in loans | |||||
| Proceeds from bank-owned life insurance | |||||
| Capital expenditures of premises and equipment | |||||
| Investment in limited partnerships | |||||
| Net cash provided by investing activities | |||||
| Cash Flows From Financing Activities: | |||||
| Increase in demand deposit and savings accounts | |||||
| Net (decrease) increase in time deposits | |||||
| Partial redemption of junior subordinated debentures | |||||
| Net decrease is short-term borrowings | |||||
| Proceeds from exercise of stock options | |||||
| Dividends on common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...